EHRA EUROPACE 2013 - European Society of Cardiology

MOndAy 24 JUnE 2013 - AFTERNOON
12:45 - 13:45 satellite symposium santorini
Fresh perspectives on hemodynamic ambulatory optimisation in CRT
sponsored by sorin Group
Chairpersons: C.W. israel (bielefeld, dE); H. burri (Geneva, CH)
Recurrent optimisation of AV- and VV timing in CRT devices has shown to improve the rate of patients
responding favorably to this therapy. In this symposium we will discuss state-of-the-art, recurrent
hemodynamic device-based optimisation and its impact on daily clinical practice, as well as the costeffectiveness
of such practice
12:45 Rationale for hemodynamic systematic CRt optimisation. 408
F.D. Murgatroyd (London, GB)
13:05 What does hemodynamic device-based optimisation bring to my daily practice? 409
M.M. Oliveira (Lisbon, PT)
13:25 Health economic benefits of optimisation. 410
A. Proclemer (Udine, IT)
12:45 - 13:45 satellite symposium Hydra
Will percutaneous mitral valve repair impact your management of
patients with mitral regurgitation?
sponsored by Abbott Vascular
Chairpersons: A. Auricchio (lugano, CH); K.-H. Kuck (Hamburg, dE)
12:45 introduction. 411
A. Auricchio (Lugano, CH)
12:55 How to perform a percutaneous mitral valve repair. 412
C. Butter (Bernau/Berlin, DE)
13:05 Reaching 10.000 patients treated, what are the data telling us? 413
S. Baldus (Hamburg, DE)
13:25 Which patients are candidates to PMVR? 414
C. Butter (Bernau/Berlin, DE)
13:40 take home messages. 415
K.-H. Kuck (Hamburg, DE)
77
monday
sessions